Trial record 1 of 1 for:    NCT01142401
Previous Study | Return to List | Next Study

Fulvestrant With or Without Bortezomib in Patients With Inoperable Locally Advanced or Metastatic Estrogen Receptor Positive Breast Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01142401
Recruitment Status : Active, not recruiting
First Posted : June 11, 2010
Last Update Posted : October 5, 2017
Information provided by (Responsible Party):
National Cancer Institute (NCI)

No Study Results Posted on for this Study
  Recruitment Status : Active, not recruiting
  Actual Primary Completion Date : June 1, 2017
  Study Completion Date : No date given